Palestine Osteoporosis Prevention Society’s mobile screening program

POPS awareness and screening project in the West Bank, using the IOF One-Minute Osteoporosis Risk Test, FRAX and ultrasound.

The Palestinian Osteoporosis Prevention Society (POPS) is carrying out a program to screen up to 1000 postmenopausal women for osteoporosis risk. 

The program’s aim is to identify women with osteoporosis as well as those at high risk for which preventive and therapeutic measures could be initiated, in addition to directly enhancing awareness of osteoporosis among women and indirectly among the local community. The screening program makes use of the IOF One-Minute Osteoporosis Risk Test, FRAX, as well as Ultrasound, and then refers those at high risk for DXA assessment and follow-up.

Dr Elias Saba, POPS Director, stated:

It is an amazing and enriching experience to be in contact with women in their respective local and rural communities, to see them discussing issues related to bone heath and giving each other tips or recipes  extracted from their traditions and own environment regarding bone healthy meals, something that you will not see in urban areas."

The screening program will also give POPS researchers the opportunity to evaluate osteoporosis risk factors in various social and economic backgrounds and to compare the results obtained from the IOF One-Minute Osteoporosis Risk Test (an awareness-raising questionnaire) to that of validated screening tests (Ultrasound system and FRAX Tool) so as to have a reference for future interventions and campaigns as well as to eventually refine the local FRAX threshold for DXA screening or management.

Currently, POPS is running the mobile screening program for postmenopausal women in the Northern part of the West Bank. This continues the program which was started last year in the Southern part of the West Bank, where 489 postmenopausal women were screened. The total number of women screened will be around 1000 women by the end of the project.  Women who are identified as having osteoporosis or being at high risk will be referred for proper diagnosis (DXA) and appropriate management and follow up.